By Grace Yoon
Shares of SkinHealth Systems rose as the medical aesthetics company said it received new FDA clearance for its SkinStylus microneedling device.
The stock was up 39% to $1.05 in recent trading, but fell 26% since the start of the year.
Chief Innovation Officer Whitney Cypes said the approval better positions the company to compete within a growing microneedling industry.
The company said in 2025 that consumer spend on microneedling in U.S. aesthetic practices rose 33%.
The device will improve the appearance of periorbital wrinkles, facial acne scars and surgical or traumatic hypertrophic scars on the abdomen, SkinHealth said.
Write to Grace Yoon at grace.yoon@wsj.com